Monday - Thoracic Surgery News

Monday Issue 

MONDAY 

7:30 A.M. – 7:45 A.M. Annual Business Meeting 

(AATS Members Only) 

7:45 A.M. Plenary Scientific Session 

9:05 A.M. Award Presentations 

10:00 A.M. Basic Science Lecture: “Update on 

Surgical-Pathologic Correlates of Valvular 

Heart Disease,” William D. Edwards, MD 

10:40 A.M. Plenary Scientific Session continues 

11:25 A.M. Presidential Address: On 

Leadership and Scholarship – Unintended 

Consequences, Unexpected Opportunity, 

Hartzell V. Schaff, MD 

2:00 P.M.– 5:00 P.M. Simultaneous Scientific 

Sessions 

Adult Cardiac Surgery 

Congenital Heart Disease 

General Thoracic Surgery 

Perioperative Care 

Basic Science Lecture: 

William D. 

Edwards, MD 

illiam D. Ed- 

MD, will Wwards, 

present the Basic Science 

Lecture, “Update 

on Surgical-Pathologic 

Correlates of Valvular 

Heart Disease” at 

10:00 a.m. on Monday 

morning. Dr. Edwards, 

a member of 

both the anatomic 

pathology department 

Schedule on page 8 

WILLIAM D. 

EDWARDS, MD 

and the laboratory of medicine and pathology 

at the Mayo Clinic in Rochester, Minn., 

has published widely on the topic of cardiovascular 

pathology. 

Visit AATS Daily News and 

THORACIC SURGERY NEWS online: 

www.thoracicsurgerynews.com 

MARTIN ALLRED 

MINNEAPOLIS CONVENTION CENTER • MINNEAPOLIS, MN • MAY 4 – 8, 2013 

Sunday’s Adult Cardiac Surgery 

Symposium Highlighted Innovations 

Sunday’s AATS/STS Adult Cardiac Surgery Symposium 

opened with presentations examining 

the complex issues involved in mitral valve repair. 

This included a debate on whether minimally invasive 

or open trans-sternal techniques were the 

preferred treatment. 

Aubrey C. Galloway, Jr., MD, of New York University, 

advanced the case for minimally invasive approaches, 

while Patrick M. McCarthy, MD, of 

Northwestern University, supported open techniques. 

Tirone E. David, MD, of Toronto General Hospital 

examined the issue of when to perform an aortic 

valve-sparing operation in the case of an aortic root 

aneurysm and when to replace the valve. He stressed 

the need for appropriate patient selection and a high 

level of technical expertise in order to obtain the best 

outcomes. 

Surgery Symposium on page 3 

General Thoracic Skills Course Bridged the 

Gap Between Capability and Excellence 

The General Thoracic Skills 

Course, held on Saturday, 

chaired by Stephen D. Cassivi, 

MD, of the Mayo Clinic, was designed 

to present new operations 

and techniques and how to perform 

them safely. 

Subsessions were grouped by 

Kazuhrio Yasufuku, MD, reviewed the advantages of Endobronchial 

Ultrasound-transbronchial needle aspiration for lymph node access. 

The characteristics of aortic cusps are key to a mitral 

valve repair strategy, said Tirone E. David, MD. 

minimally invasive diagnostics and 

therapeutics, esophagectomy, pulmonary 

resection, and the mediastium. 

Kazuhiro Yasufuku, MD, of the 

University of Toronto, addressed 

the role of Endobronchial Ultrasound 

(EBUS)–transbronchial needle 

aspiration (TBNA) as a novel 

approach that is both safe and has a 

good diagnostic yield and can access 

all lymph node stations accessible 

by mediastinoscopy and the 

hilar lymph nodes. 

“EBUS-TBNA is less invasive, 

safer, and as accurate as surgical 

staging for NSCLC patients who 

have discrete mediastinal lymph 

node enlargement,” Dr.Yasufuku 

concluded. 

Neil A. Christie, MD, of the University 

of Pittsburgh, discussed 

how thoracic surgeons are ideally 

General Thoracic Skills on page 17 

Correction 

I 

n Sunday issue’s coverage of 

the Plenary Scientific Session, 

the name of the PROACT trial 

was misidentified. PROACT 

stands for Prospective Randomized 

On-X Anticoagulation 

Clinical Trial. 

MARTIN ALLRED

The World’s Only 

FULLY ROTATABLE 

HD Bronchoscopes 

Introducing a New Era in Bronchoscopy 

Visit our booth #1730 for a demonstration of the revolutionary Rotary Function. 

Only from Olympus. 

©2013 Olympus America Inc. Registered Trademark of Olympus or its affiliates. www.olympusamerica.com OAIRES0113AD10480

MINNEAPOLIS CONVENTION CENTER • MINNEAPOLIS, MN • MAY 4 – 8, 2013 AATS 93 RD ANNUAL MEETING 3 

Surgery Symposium from previous page 

Gosta B. Pettersson, MD, recommended allografts 

for surgical reconstruction after endocarditis. 

MARTIN ALLRED 

The AATS Graham Research Foundation 

David J. Sugarbaker, MD 

Since its founding in 1973, the 

AATS Graham Research Foundation 

has served as the funding 

arm of the AATS’ research 

initiatives. The core mission of the 

Foundation is focused on driving 

leadership, learning and innovation in 

the pursuit of excellence. 

“As thoracic surgeons, each of us 

lives this mission every day by mentoring, 

supporting and guiding our 

colleagues,” said David J. Sugarbaker, 

MD, Foundation President. 

“The Foundation strives to advance 

the specialty by providing the bestpractice 

models in cardiothoracic 

surgery scholarship and research. Although 

the ways in which we fulfill 

our mission evolve as the specialty 

grows, we remain faithful to our values 

of academic exchange, innovation 

and collaboration, advancing 

patient care, fostering leadership, and 

trusted stewardship.” 

“We are pleased to announce this 

year’s recipients who have been identified 

as surgeons of unique promise 

who exhibit the potential for international 

thoracic surgical leadership.” 

Min Peter Kim, MD, of the United 

Methodist Hospital and United 

Methodist Hospital Research Center, 

Houston, Weill Cornell Medical 

School, New York, and The University 

of Texas MD Anderson Cancer 

Center, Houston, is the recipient of 

this year’s John W. Kirklin Research 

Scholarship. Dr. Kim will focus his research 

studying lung cancer microenvironment 

and metastasis. 

The 2013 Graham Traveling Fellow 

is Dr. Haifeng Wang, of Shanghai 

Pulmonary Hospital, Shanghai 

China. Dr. Wang’s fellowship goal is 

to gain an insight into leading techniques 

in current general thoracic 

surgery, such as airway surgery, thoracoscopic 

surgery and lung transplantation. 

He will be hosted by Dr. Douglas 

J. Mathisen, Massachusetts General 

Hospital, Dr. Alec Patterson, Barnes 

Jewish Hospital in St. Louis, and Dr. 

Robert McKenna, at Cedars-Sinai in 

Los Angeles. 

In the years ahead, the Foundation 

will continue to develop new initiatives 

of value to the cardiothoracic 

surgery specialty and to fulfill the 

AATS and AATS Graham Research 

Foundation’s mission. 

“We envision a dynamic and innovative 

future of continued excellence 

for cardiothoracic surgery,” concluded 

Dr. Sugarbaker. 

Michael R. Petracek, MD, reviewed strategies to avoid 

left ventricular rupture after mitral valve surgery. 

“The single most important criterion to save the 

aortic valve is the quality of aortic cusps, which 

have to be normal or have only minor abnormalities 

that can be satisfactorily corrected at the time 

of surgery without having to augment them with 

foreign materials,” Dr. David pointed out. 

Transesophageal echocardiography is the best diagnostic 

tool. The number of cusps, their thickness, 

the appearance of their free margins, and the 

excursion of each cusp during the cardiac cycle 

must be examined in multiple echocardiographic 

views. 

“If the aortic cusps are thin, mobile, and have 

smooth free margins, the feasibility of AVS is 

very high, even in the case of bicuspid aortic 

valves,” said Dr. David. Patients with abnormal 

cusps are best treated with aortic root replacement, 

he added. 

Michael R. Petracek, MD, of Vanderbilt University 

Medical Center, discussed the best means of 

preventing left ventricular rupture following mitral 

valve surgery, which he called “one of the most 

dreaded complications in cardiovascular surgery, 

with a mortality rate between 30% and 90%.” He 

gave a variety of prevention tips, including preserving 

as much of the mural leaflet and its chordae 

as possible; the careful removal of only as 

much calcium as is necessary to implant an adequate-sized 

valve; the use of bovine pericardium to 

repair the defect and implant the valve if the annulus 

is totally decalcified; the use of a low profile 

valve; and careful sizing, especially avoiding oversizing. 

Dr. Petracek also warned against placing valve 

sutures deeply below the annulus through the ventricular 

muscle or calcium, and he suggested using 

a pericardial skirt between the left atrium and the 

valve sewing ring. 

Gosta B. Pettersson, MD, of the Cleveland 

Clinic, presented the latest techniques and results 

for reconstructing the fibrous skeleton. 

“Surgical management of advanced endocarditis 

is difficult and requires an experienced cardiac 

surgeon,” Dr. Pettersson said, pointing out that 

radical debridement of all infected necrotic tissue 

and foreign material is the first step toward 

curing the infection. 

When it came to reconstruction, he recommended 

the use of allografts, which have shown 

benefits in both hospital mortality and mediumterm 

survival. “When an aortic allograft was 

used for reconstruction, mortality was 3.9% for 

prosthetic aortic valve endocarditis and 3.7% for 

infected ascending and arch prosthetic grafts,” 

Dr. Pettersson said. 

The session closed with an examination of the 

latest practice models in cardiac surgery, both private 

and academic, focusing on the benefits of an 

integrated cardiovascular practice. 

Dr. Bruce Lytle, of the Cleveland Clinic, discussed 

how traditional departments such as cardiovascular 

medicine, cardiovascular surgery, and 

vascular surgery (while retaining their department 

chairperson) can be integrated through the supervision 

of an “institute chair,” who is a physicianadministrator 

clinically involved with that 

pertinent organ system. Budget projections are 

based on both the departments and upon the institute 

as a whole, with strategic planning carried out 

mostly on the institute level, he said. 

“So far, the advantages of this system have included 

rationalization of resources, the sharing of 

resources among departments, programmatic development 

among departments and sections of departments, 

and rationalization of recruiting. The 

continual interaction also has appeared to lead toward 

increased collegiality,” concluded Dr. Lytle. 

Presidential 

Address 

Today 

The Presidential Address, 

“On Leadership and Scholarship 

– Unintended Consequences, 

Unexpected 

Opportunity,” 

will be 

given at 

11:25 a.m. 

by Hartzell 

V. Schaff, 

MD. 

Dr. Schaff 

is the Stuart 

W. Harrington 

Professor 

of Surgery at 

HARTZELL V. 

SCHAFF, MD 

the Mayo Clinic in Rochester, 

Minn., and is a member of both 

the Cardiovascular Surgery and 

Pediatric and Adolescent Medicine 

Departments. 

MARTIN ALLRED

4 AATS 93 RD ANNUAL MEETING MINNEAPOLIS CONVENTION CENTER • MINNEAPOLIS, MN • MAY 4 – 8, 2013 

Luncheon Symposium: 

The Price of Innovation 

In a special Sunday luncheon symposium, 

Albert Starr, MD, Professor 

of Surgery, Distinguished 

Professor of Cardiovascular Medicine 

at Oregon Health and Science 

University (OHSU), highlighted the 

importance of “money, brain power 

and collaboration” in driving health 

care innovation in the U.S. at a time 

when federal funding is shrinking, 

but rising in other countries (by as 

much as 67% in China and 24% in 

South Korea). 

He called on the audience to 

work on enhancing the role of 

philanthropy and venture capital 

in advanced medical research, and 

to strengthen relationships with 

novel entities like healthcare accelerators 

or the recently launched 

Medical Device Innovation Consortium. 

Dr. Starr, best known for his work 

developing and implanting the first 

artificial heart valve, also tackled 

the controversial topic of immigration, 

highlighting recent recommendations 

by the Brookings Institute 

designed to encourage retention of 

U.S.-trained researchers in the fields 

of science, technology, engineering 

and math. 

He reminded the audience, that 

while there are great risks, “innovation 

can be great fun.” 

Congenital Heart Symposium: Focus on Reoperation 

Many patients treated for congenital 

heart disease need repeated 

interventions and 

operations over the course of their 

lifetime. With the increased number 

of procedures comes increased complexity 

and often worse outcomes. 

Reoperation in children and adults 

with congenital heart disease was the 

focus of the Congenital Heart Disease 

Symposium, chaired by Joseph 

Dearani, MD, of the Mayo Clinic. 

Jeffrey P. Jacobs, MD, of All Children’s 

Hospital, detailed the benefits 

Albert Starr, MD 

Jeffrey P. Jacobs, MD, discussed the utility of the STS- 

CHSD for research on congenital heart reinterventions. 

of using the Society of Thoracic Surgeons 

(STS) database and what it can 

tell surgeons about reoperation in 

the congenital heart disease population. 

In order to determine what the 

STS–Congenital Heart Surgery Database 

(STS-CHSD) could do to help 

inform understanding of the considerable 

problem of reoperation, Dr. 

Jacobs, and his colleagues interrogated 

the database. 

“As a surrogate for reoperation, we 

stratified operations in the STS-CHSD 

by the variable: ‘Number of Prior 

CPB Cardiothoracic 

Operations,’ ” said Dr. 

Jacobs. He and his colleagues 

examined discharge 

mortality, 

postoperative length 

of stay, and other variables 

stratified by the 

number of prior CPB 

cardiothoracic operations. 

Although the 

results varied widely 

based on operation 

type, they provided 

important data. 

MARTIN ALLRED 

For example, the 

value of multi-institutional 

data is exemplified 

by 

MARTIN ALLRED 

Focus On Managing Patients 

at Critical Care Session 

Sunday’s AATS/STS 

Cardiothoracaic 

Critical Care Symposium 

featured a presentation 

by Nevin M. Katz, 

MD, of Johns Hopkins 

University, addressing 

how CT clinical care can 

meet the challenges of 

modern practice. Dr. Katz 

focused on the need for 

cardiovascular thoracic 

critical care to be performed 

by a multidisciplinary 

team. He discussed 

the problems of managing 

patients with severe CHF, 

acute lung injury, and coagulopathy. 

Daniel T. Engelman, MD, 

of Baystate Medical Center, 

spoke on the latest developments 

in the area of hemodynamic 

and respiratory 

monitoring in the ICU and 

how these can improve care 

and help reduce errors. 

outcomes after a Fontan reoperation. 

Fontan conversion was developed 

by Constantine Mavroudis, 

MD, (another speaker at the session) 

who reported an early mortality of 

less than 1%. But according to the 

STS-CHSD, these results are not being 

matched, with early mortality 

after Fontan revision or conversion 

(Re-do Fontan) being 10.07%, indiciating 

room for considerable improvement, 

according to Dr. Jacobs. 

“Analysis of the database shows 

that patients undergoing reoperation 

after prior CPB cardiothoracic operations 

present a challenging problem. 

However, the data show that most 

forms of surgical treatment in this 

subgroup offer a reasonable chance of 

survival,” Dr. Jacobs concluded. 

Dr. Dearani spoke on approaching 

a high-risk reoperation and the best 

strategies for conducting the operation 

in order to lower the risk as 

much as possible. 

“Cardiac injury during resternotomy 

in a patient with congenital 

heart disease is likely to be related 

to a rent in an extracardiac conduit, 

dilated aorta, dilated right ventricle 

or right atrium, or the innominate 

vein. 

An algorithm used at his institution 

Nevin M. 

Katz, MD (top) 

and Daniel T. 

Engelman, MD 

(bottom) 

spoke on 

practical 

management 

issues in 

cardiothoracic 

critical care. 

Joseph Dearani, MD, discussed the 

challenges of high-risk reoperations. 

for dealing with a hazardous reoperation 

included particular care in confirming 

the presence or absence of 

intracardiac shunts, and determining 

ventricular and valvar function 

through the use intraoperative 

echocardiography. 

“In general, for right-sided procedures 

we maintain systemic normothermia 

or mild hypothermia, and for 

left-sided procedures or combined 

right and left-sided procedures we use 

moderate hypothermia,” Dr. Dearani 

advised. 

PHOTOS NICK PIEGARI 

MARTIN ALLRED

Visit Sanofi booth 837 

for more information and a 

hands-on demonstration 

Manufactured by 

Genzyme Corporation, a Sanofi Company 

175F New Boston Street 

Woburn, MA 01810 USA 1-800-261-1570 

LeGoo is a registered trademark of Genzyme Corporation, a Sanofi Company. 

©2013 Genzyme Corporation. All rights reserved. US.LEG.13.03.008


Allied Health Personnel Symposium a Success 

In Saturday’s Allied Health Symposium, 

Gorav Ailawadi, MD, of the 

University of Virginia, discussed 

the revolutionary effect of percutaneous 

aortic valve therapy. He reviewed 

the Partner I trial in the 

United States, and then detailed two 

additional ongoing trials, which have 

either completed enrollment or are 

still enrolling, including the SUR- 

TAVI (CoreValve, Medtronic) and 

the PARTNER II (Sapien XT Valve, 

Edwards) trials. 

The PARTNER II trial is currently 

in enrollment and consists of two trials 

similar to the Partner I trial and is 

evaluating the second-generation 

Gorav Ailawadi, MD, reviewed the 

Partner I trial, and two other ongoing 

valve trials, PARTNER II and SURTAVI. 

Sapien XT valve (which has a smaller 

delivery sheath). The Partner 2B trial 

randomized inoperable patients to 

the Sapien or the Sapien XT valve 

and completed enrollment roughly 1 

year ago. Results are expected from 

this trial in the near future, according 

to Dr. Ailawadi. 

The SURTAVI trial, using the selfexpanding, 

transcatheter CoreValve 

(Medtronic) tested the therapy in 

high risk and extreme risk for surgery 

patients. This trial has completed enrollment 

but study results are still 

pending. Currently, the SURTAVI trial 

is enrolling patients at intermediate 

risk for surgery to compare the 

CoreValve to conventional surgery. 

“Although TAVR has revolutionized 

the approach to aortic stenosis, 

and its use is expected to rapidly increase 

over the next several years, 

the need to evaluate the current status 

of the technology, to carefully 

evaluate candidate patients, and to 

be aware of the various risks of this 

technology is still critically important,” 

Dr. Ailawadi concluded. 

Robert J. Cerfolio, MD, of the University 

of Alabama, presented an update 

of the status of robotic thoracic 

surgery. “Robotic surgery of some 

type is the future of most surgical 

procedures due to its many benefits, 

including an enhanced view of the 

operative field and smaller instrumentation 

with more freedom of 

movement,” he said. 

However, not every CT surgeon 

should attempt robotic pulmonary 

resections, according to Dr. Cerfolio. 

“It is the surgeon and his/her team 

who must be fully committed to this 

process because they believe it adds 

value to their patient care, not to the 

hospital’s financial statements,” Dr. 

Cerfolio said. And the surgeon’s qualifications 

are paramount. The surgeon 

needs a thorough understanding of 

the 3-D anatomy of the chest, regardless 

of observational view. 

He outlined the many team characteristics 

associated with a successful 

robotic program and the kind of 

training needed. 

Other presentations in the day-long 

session included such diverse subjects 

as anticoagulation management, 

blood conservation techniques, and 

the evolving role of ventricular assist 

devices. 

AATS Allied Symposia 

Monday, May 6 th 

12:30 pm -2:00 pm 

Exhibit Hall Product Theater 

Lifetime Management of Aortic 

Stenosis: The Changing Landscape 

Supported by Medtronic 

5:30 pm - 7:30 pm 

Gaining Clarity on Competitive Flow: 

Implications for Improved CABG 

Outcomes 

Supported by Medistim 

Robert J. Cerfolio, MD, discussed 

robotic thoracic surgery and the 

importance of teaching and team 

building to develop and maintain 

a successful robotic program. 

Tuesday, May 7th 

12:30 pm - 2:00 pm 

Exhibit Hall Product Theater 

Improving Outcomes for Coronary 

Bypass Surgery 

Supported by Maquet 

Tuesday Forum to Tackle Tough Cardiac Surgery Questions 

PHOTOS MARTIN ALLRED 

Research findings presented in 

Tuesday morning’s cardiac 

surgery forum will help clarify 

some of the most vexing questions 

faced by cardiothoracic surgeons today. 

The forum will be moderated by 

Joseph Woo, MD, of the University 

of Pennsylvania, and Gorav Ailawadi, 

MD, of the University of Virginia. 

Papers will address valve surgery, 

coronary artery bypass grafting 

(CABG), left ventricular assist devices 

(LVAD), atrial fibrillation (Afib), and 

aortic surgery, “the five major branches 

of heart surgery,” said Dr. Woo. 

Two papers address who to select 

for transcatheter aortic valve replacement 

and who might be better off 

with a traditional open procedure. An 

Italian team compared outcomes for 

both in almost 1,000 patients. To help 

patients decide between the two approaches, 

researchers from the Mayo 

Clinic in Rochester, studied how well 

500-plus patients at moderate risk for 

JOSEPH WOO, MD 

GORAV AILAWADI, MD 

surgical mortality did with the traditional 

approach. 

“This is a hot topic,” Dr. Woo said. 

The field is “basically trying to decide 

whether patients should go for a 

standard operation and incur the 

risks of surgery, or undergo this 

catheter based procedure.” 

Two LVAD studies will also be presented. 

The first, from Pennsylvania 

State University, tackles what can go 

wrong and the role of anticoagulation; 

the second, from Duke University 

and other schools, looks into the 

safety of fixing valve problems during 

LVAD placement. 

“LVAD is huge now. [It’s] probably 

the largest growth area in all of cardiovascular 

surgery, probably because 

heart failure is the largest growth 

area in all of cardiovascular medicine. 

There are a lot of concomitant 

valvular lesions that can [have a] major 

impact when putting in an LVAD. 

There are groups out there that advocate 

being very aggressive about attacking 

these valve lesions at the 

time of surgery,” Dr. Woo said. 

Three CABG studies will address 

newer issues with the procedure. Researchers 

from Stony Brook University, 

tested a new rapid platelet activity 

test to see how well it predicted postop 

bleeding in 150 patients on clopidogrel; 

a team from the University of 

Virginia investigated if it’s possible to 

hit the 1% surgical mortality goal set 

by leaders in the field; and Canadian 

researchers examined if artery graft 

patients, like vein graft patients, die 

sooner if the heart isn’t totally revascularized. 

Artery grafts are known to last far 

longer than vein grafts, so “we are 

getting the sense that more arteries 

are better,” but because there’s a limited 

supply of them, going the allartery 

route may mean that “you 

can’t target all the [areas] that you 

want to graft.” It hasn’t been clear 

what that means for patients. The 

feasibility of dropping the current nationwide 

CABG mortality rate from 

2% to 1% hasn’t been clear, either. 

Mayo Clinic investigators also pitted 

cryothermy and radiofrequency ablation 

against traditional Cox-Maze III 

surgery for atrial fibrillation. 

The thinking has been that “you 

can most likely achieve the same effect 

as [Cox-Maze cutting] with a 

burn or a freeze or microwave or 

laser energy,” Dr. Woo said, but definitive 

evidence has been lacking.

VISIT US AT AATS BOOTH #419 

non-narcotic pain relief means 

Better outcomes. Satisfied patients. 

With the ON-Q* non-narcotic pain relief system, patients: 

• Went home an average of 1.1 days sooner 

• Reported up to 69% lower pain scores 

• Were up to 3x as likely to report high satisfaction scores 

• Are more likely to experience better pain management with fewer side effects 

Every day without 

costs you more. 

See how ON-Q* can help you. Call your ON-Q* representative 

today for a complimentary consultation: 1-888-962-4ONQ (4667). 

Visit iflo.com today to view our extensive online library of peer-reviewed journal articles, papers, posters and additional clinical trial information. 

There are inherent risks in all medical devices. Please refer to the product labeling for Indications, Cautions, Warnings, and Contraindications. Failure to follow the product labeling could directly impact patient 

safety. Physician is responsible for prescribing and administering medications per instructions provided by the drug manufacturer. Refer to www.iflo.com for product safety Technical Bulletins. 

I-Flow*, LLC, A Kimberly-Clark Health Care Company 20202 Windrow Drive, Lake Forest, California 92630 USA ON-Q* Pain Relief System *Registered trademark or trademark of Kimberly-Clark 

Worldwide, Inc. ©2013 KCWW All rights reserved.


Academic Surgeon Career Challenging, But Rewarding 

Juggling the demands of academia 

while maintaining a clinical 

surgical practice can be 

daunting, but Saturday morning’s 

“Developing the Academic Surgeon” 

session showed how it was 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

not only possible, but rewarding. 

Peter J. Gruber, MD, of the Primary 

Children’s Medical Center, addressed 

the problems of doing both 

surgery and science well. “It is geometrically 

more difficult, but not 

impossible,” he said, outlining what 

he called “the challenges and joy of 

developing a basic research program 

within a surgical milieu. 

“Compromise of the clinical enterprise 

is not a viable option, yet nei- 

 

 

 

 

 

 

ther is compromise of the scientific 

one,” he stressed. 

“For example, genetic studies that 

require validation should either be 

validated or published as hypotheses, 

and animal studies lacking 

mechanism should go back to the 

drawing board until there is one,” he 

said. 

“It is critical to sustain and nurture 

the highest levels of academic rigor 

as surgeon-scientists to advance the 

noble legacy of our profession as we 

continue to care for patients,” Dr. 

Gruber concluded. 

Peter J. Gruber, MD, advised combining 

clinical and academic pursuits. 

Schedule from page 1 

TUESDAY 

7:00 A.M. Cardiac Surgery Forum 

General Thoracic Surgery Forum 

8:45 A.M. Plenary Scientific Session 

11:40 A.M. Honored Speaker 

Lecture: Interview with former 

Vice President Dick Cheney: 

Personal Reflections on Cardiac 

Surgery 

2:00 P.M. – 5:00 P.M. Simultaneous 

Scientific Sessions 

Adult Cardiac Surgery 

Congenital Heart Disease 

General Thoracic Surgery 

Aortic/Endovascular Surgery 

5:15 P.M. – 5:45 P.M. Executive 

Session 

(AATS Members Only) 

WEDNESDAY 

7:00 A.M. Emerging Technologies 

and Techniques Forum 

9:00 A.M. Controversies in 

Cardiothoracic Surgery 

10:00 A.M. Simultaneous Sessions 

Adult Cardiac Debate 

Congenital Debate 

General Thoracic Debate 

11:00 A.M. Transcatheter Therapy 

and Collaboration: Defining Our 

Future 

2:30 P.M. 93rd Annual Meeting 

Adjourns 

MARTIN ALLRED


New ‘Working With Industry’ Course Aids Innovators 

By bringing the physician inventors 

on the stage with industry, 

the new “Working with 

Industry” course held on Saturday 

afternoon was designed to help 

those surgeons interested in translating 

their innovative ideas to commercial 

success, according to course 

chair Patrick M. McCarthy, MD, of 

Northwestern University. 

Thomas J. Fogarty, MD, the 

renowned medical device entrepreneur, 

as well as William E. Cohn, 

MD, Steven F. Bolling, MD, and Marc 

Gillinov, MD, each spoke to a different 

aspect of the innovation process. 

Dr. Fogarty, inventor of the eponymous 

catheter, opened the course 

with a lively description of the historical 

path to device innovation, using his 

own vast experience as an example. 

His path was different from today in 

terms of testing, regulation, and commercialization, 

but in many ways is 

still the same in terms of the creative 

process and the dogged persistence 

needed to get from the original idea to 

a functional and commercial device. 

Dr. Gillinov of the Cleveland 

Clinic Foundation, the 

co-developer of the Atri- 

Clip, a left atrial appendage 

clip designed for open or 

minimally-invasive occlusion 

of the left atrial appendage, 

discussed the role 

device development in the 

university setting, and how 

the often maligned Office 

of Technology Transfer at 

these institutions can be a 

significant boon to the inventor. 

Most academic medical 

centers and university contracts 

mandate that any inventions 

developed by their employees are assigned 

to the institution. 

“This is standard,” said Dr. Gillinov. 

“They all want to benefit from ‘The 

Gatorade Effect,’ ” he explained, describing 

how the University of Florida 

has received over $100 million in royalties 

because U.F. professor Robert 

Cade, a kidney specialist, invented the 

huge moneymaker, Gatorade. 

Stop By the AATS 

Welcome Center 

Stop by the AATS Welcome 

Center, located in the lobby 

area next to registration at the 

Minneapolis Convention Center. 

The Welcome Center is your onestop 

resource for questions regarding 

the AATS, Annual Meeting and 

information on the city of Minneapolis. 

AATS staff will be available at the 

center to answer your questions on 

AATS initiatives, including AATS 

publications, membership, upcoming 

educational meetings, awards, 

and scholarships. 

Copies of The Journal of Thoracic 

and Cardiovascular Surgery and Thoracic 

Surgery News will be available. 

Patrick M. McCarthy, MD, course chair, introduced the speakers, Thomas J. Fogarty, MD; 

William E. Cohn, MD; Steven F. Bolling, MD; and Marc Gillinov, MD. The discussion focused 

on experience and advice on bringing medical inventions and innovations to the market. 

So it behooves universities to help 

inventors in any way they can, and 

for academic employees to make the 

most of the resources available. 

“They can be helpful, if you play 

your cards right,” said Dr. Gillinov. 

The Office of Technology Transfer 

can help you assess the commercial 

opportunities for your invention and 

help you write and submit the 

patent. The Office can aid in deciding 

whether to license your invention or 

to form a new company. It can even 

help broker strategic alliances with 

industry. In addition, one of the most 

important ways the Office can help is 

in the area of financial support, including 

identifying investors. Another 

important function they can serve is 

to help the surgeon-inventor navigate 

the increasingly complex area of conflict 

of interest issues, Dr. Gillinov 

added. 

A roundtable panel discussion with 

industry representatives and a 

spokesperson from FDA was co-moderated 

by Dr. Michael J. Mack and 

concluded the course with tips for 

the new inventor, as the panel also 

fielded questions from the audience. 

MARTIN ALLRED 

Stop by the Welcome Center to get information on the AATS and the 

Minneapolis area. 

MARTIN ALLRED


AATS Exhibit Hall Hours 

Monday, May 6, 2013 

9:00 am – 4:30 pm 

Tuesday, May 7, 2013 

9:00 am – 4:00 pm 

A & E Medical Corporation 1631 

2310 South Miami Blvd., Suite 240 

Durham, NC 27703-5796 

Acute Innovations 526 

21421 NW Jacobson Road, Suite 700 

Hillsboro, OR 97124 

www.acuteinnovations.com 

Furthering their reputation as a leader in the 

thoracic industry, ACUTE Innovations® continues 

to make advancements in chestwall stabilization 

technology. Stop by booth 526 to learn 

about ACUTE’s cutting-edge products: the RibLoc® 

Rib Fracture Plating system, Biobridge® 

Resorbable Chest Wall Stabilization Plate, and 

the AcuTie® Sternal Closure System. 

AME Publishing Company 539 

3/F, Building 1#, Lesu Science Park, 1526 

Chunbo Road, Binjiang district 

Hangzhou, China 

www.amepc.org 

The Annals of Cardiothoracic Surgery is a bimonthly 

peer-reviewed publication, dedicated to 

the field of cardiothoracic surgery. Each issue is 

overseen by a special Guest Editor and features 

operative videos provided by renowned surgeons. 

The Journal of Thoracic Disease is a bi-monthly, 

international, Pubmed-indexed journal with a 

primary focus on thoracic disease. 

ATMOS, Inc. 745 

3717 Huckleberry Road 

Allentown, PA 18104 

www.atmosmed.com 

Atmos offers the S201 Thorax Drainage Monitoring 

System. Our advanced digital chest 

drainage system allows for patient mobility while 

maintaining suction, quantifies drainage flow in 

L/min, requires less intervention and ultimately 

a reduction in length of stay for the patient. 

2013 AATS Annual Meeting Exhibitors 

AtriCure, Inc. 1419 

6217 Central Park Drive 

West Chester, OH 45069 

www.atricure.com 

AtriCure, Your Partner in Afib Solutions, featuring 

the only FDA approved surgical AF device, 

Synergy RF, and Cryothermic Ablation energy 

devices. Providing the only Maze IV AF certification 

course. AtriCure’s portfolio includes the 

AtriClip®, which is the ONLY Complete LA Appendage 

management solution that permanently 

isolates both mechanically and electrically. 

Atrium Medical Corporation - a MAQUET 

Getinge Group company 929 

5 Wentworth Drive 

Hudson, NH 3051 

www.atriummed.com 

Atrium is now part of MAQUET Getinge Group. 

Express Mini 500TM and PneumostatTM Mobile 

Chest Drains, OceanTM Water Seal, OasisTM 

Dry Suction & ExpressTM Dry Seal Chest 

Drains. Coated & uncoated PVC & Silicone Thoracic 

Catheters, PleuraGuideTM Disposable 

Chest Tube Kit, Cardiac Surgery Devices & 

complete line of Aortic Vascular Grafts. 

Baxter Healthcare 627 

One Baxter Parkway 

Deerfield, IL 60015 

www.baxter.com 

Baxter is a global, diversified healthcare company 

with expertise in medical devices, pharmaceuticals, 

and biotechnology. The company 

continues its quest for advancing BioSurgery by 

offering a comprehensive line of products for 

hemostasis and sealing, adhesion reduction solution, 

and preparation/delivery devices based 

on the latest scientific advances in the field. 

Berlin Heart 520 

200 Valleywood Rd., Ste. A500 

The Woodlands, TX 77380 

www.berlinheart.com 

Berlin Heart, the only company worldwide, that 

develops, manufactures and distributes VADs 

for patients of every age and body size. EX- 

COR® Pediatric provides medium to long-term 

circulatory support specifically for infants and 

children awaiting heart transplants. EXCOR Pediatric 

is approved for use in the USA under 

HDE regulations by the FDA. 

AATS Daily News Advertisers 

BFW, Inc. 1029 

2307 River Road, #103 

Louisville, KY 40206 

www.bfwinc.com 

Recognized worldwide for unmatched design 

and engineering in surgical illumination, from 

its Thru-the-Lens Headlight Video System to 

the groundbreaking 10,000-hour Chroma- 

LUME Plasmas Headlight System, or the incredibly 

bright and portable VistaView II LED, 

BWF is the technological leader offering the 

most dependable headlight illumination system 

in the medical field today. 

Biomet Microfixation 737 

1520 Tradeport Drive 

Jacksonville, FL 32218 

www.biometmicrofixation.com 

Biomet Microfixation is a leading global healthcare 

provider of orthopedic products. Our thoracic 

portfolio includes the Pectus Bar for 

repair of Pectus Excavatum and the SternaLock 

Blu Primary Closure System for sternal closure. 

The Blu System aligns and stabilizes the sternum 

after sternotomy and enables easier closure 

after minimally invasive access. 

Bolton Medical Inc. 621 

799 International Pkwy 

Sunrise, FL 33325 

www.boltonmedical.com 

Bolton Medical is a subsidiary of the Werfen 

Life Group. Werfen Life Group is an international 

company that manufactures and distributes 

medical diagnostic solutions and medical devices 

worldwide. Bolton Medical sells endovascular 

therapies for thoracic repair, such as 

Relay Thoracic Stent-Graft in both U.S. and international 

markets and Relay NBS (non-bare 

stent) in international markets. 

Cardiovascular Research Foundation 428 

111 E. 59th Street 

New York, NY 10022 

www.crf.com 

The Cardiovascular Research Foundation (CRF) 

is an independent, academically focused nonprofit 

organization dedicated to improving the 

survival and quality of life for people with cardiovascular 

disease through research and education. 

Since its inception in 1991, CRF has 

played a major role in realizing dramatic improvements 

in treating heart disease by establishing 

the safe use of new technologies, drugs, 

and therapies in interventional cardiovascular 

medicine. 

Cardivon 427 

602, Block A, Jinzun International Suite 

Huaian, Jiangsu Province, 223002 China 

Chase Medical 444 

885 E. Collins Suite #110 

Richardson, TX 75081 

www.chasemedical.com 

Chase Medical: Dedicated to providing cardiac 

surgeons innovative devices for sugery. The SVR 

System creates an elliptical ventricle every 

time. The Triumph System is a soft aortic balloon 

occlusion cannula used for minimally invasive 

valve procedures. Our beating heart 

products include heart stabilizers, shunts, blower 

misters and apical lift devices. 

Cook Medical 1310 

750 Daniels Way, P.O. Box 489 

Bloomington, IN 47402-0489 

Cormatrix Cardiovascular, Inc. 1613 

286 South Main Street Suite 200 

Alpharetta, GA 30009 

www.cormatrix.com 

CorMatrix® Cardiovascular markets its ECM® 

Technology biomaterial devices for pericardial 

closure, cardiac tissue repair, and carotid repair 

and is currently conducting preclinical 

studies to evaluate future applications in 

heart failure as well as other cardiovascular 

applications. 

CORONEO 1628 

9250 Park Avenue, #514 

Montreal, QC H2N 1Z2 Canada 

Covidien 805 

555 Long Wharf Drive 

New Haven, CT 6511 

www.covidien.com 

Covidien is a leading global healthcare products 

company that creates innovative medical solutions 

for better patient outcomes and delivers 

value through clinical leadership and excellence. 

Please visit www.covidien.com to learn 

more. 

CRC Press - Taylor 

& Francis Group LLC 939 

6000 Broken Sound Parkway NW, 

Suite 300 

Boca Raton, FL 33487 

www.crcpress.com 

CRC Press – Taylor & Francis Group is a global 

publisher of world-class references, handbooks, 

journals, and textbooks for the medical, scientific 

and technical communities including academics, 

professionals, and students. Our 

award-winning CRCnetBASE has our eBook collections. 

Visit www.crcpress.com or contact us at 

1-800-634-7064, or +44 (0) 1235 400 524. 

CryoLife, Inc. 729 

1655 Roberts Blvd. 

Kennesaw, GA 30144 

www.cryolife.com 

CryoLife® is a leader in the development and 

implementation of advanced technologies associated 

with allograft processing and cryopreservation. 

CryoLife also offers solutions for 

patients with Refractory Angina utilizing Transmyocardial 

Revascularization or TMR with the 

Cardiogenesis Holmium:YAG system. 

CTSNet 410 

www.ctsnet.org 

CTSNet (www.ctsnet.org), headquartered in 

Chicago, Illinois, USA, is the leading international 

source of online resources related to 

cardiothoracic surgery, as well as the major 

hub of the international online community of 

cardiothoracic surgeons and allied health care 

professionals. 

Continued on page 11


Continued from page 10 

Dallen Medical 522 

1046 Calle Recodo, Suite G 

San Clemente, CA 92673 

www.dallenmedical.com 

Dallen Medical, Inc. is an early stage orthopedic 

company whose patented technology provides 

superior fixation and compression. Dallen 

has FDA 510(K) clearances for its Compressyn 

band for sternal closure & the Compressyn 

for small bone fixation and expects to 

file additional 510(K)’s around its banding 

technology. 

Davol Inc., a BARD Company 1407 

60 Technology Drive 

Irvine, CA 92618 

Delacroix - Chevalier 1429 

3825 Commerce Dr. 

St. Charles, IL 60174 

www.delacroix-chevalier.com 

Famous French instrument manufacturer since 

1920, DELACROIX-CHEVALIER is proud to offer 

indisputable best-seller instruments and innovative 

devices dedicated to MIS and video 

cardio-thoracic surgery developed in cooperation 

with key opinion leaders. Specialized R&D, 

cutting edge manufacturing capabilities, and 

dynamic market strategies help Delacroix- 

Chevalier rank among world market leaders in 

the field. 

DePuy Synthes CMF 1210 

1301 Goshen Parkway 

West Chester, PA 19380 

www.synthes.com 

Synthes CMF develops, produces and markets 

instruments and implants for the surgical reconstruction 

of the human skeleton and soft 

tissues. Our product offering includes systems 

for internal fixation of the sternum following a 

sternotomy/ osteotomy or fracture of the sternum 

and rib, with options to stabilize and promote 

fusion. 

Designs For Vision, Inc. 1606 

760 Koehler Avenue 

Ronkonkoma, NY 11779 

www.designsforvision.com 

Just See It with Designs for Vision's lightweight 

custom-made Surgical Telescopes- now 

available with Nike® frames. See It Event Better 

with the L.E.D. Daylite®, the new Ultra- 

Mini L.E.D. Daylite® or trin Beam®, L.E.D. 

Daylite® providing the brightest and safest untethered 

illumination. 

Dynasil Products 1542 

44 Hunt Street 

Watertown, MA 2472 

Description to come 

EACTS 412 

Maderia Walk 

Windsor, SL4 1LU UK 

www.eacts.org 

The EACTS is the largest European Association 

devoted to the practice of Cardio-thoracic 

surgery. The main objects of the Association are 

to advance education in the field of cardio-thoracic 

surgery and to promote, for the public 

benefit, research into cardiovascular and thoracic 

physiology and therapy and to correlate 

and disseminate the useful results thereof. Visit 

the booth for information on membership, future 

meetings, EACTS Academy and all other 

activities of EACTS. 

Edwards Lifesciences 905 

One Edwards Way 

Irvine, CA 92614 

www.edwards.com 

Edwards Lifesciences is the global leader in the 

science of heart valves and hemodynamic monitoring. 

Driven by a passion to help patients, 

the company partners with clinicians to develop 

innovative technologies in the areas of structural 

heart disease and critical care monitoring 

that enable them to save and enhance lives. 

Additional company information can be found 

at www.edwards.com. 

Elmed Incorporated 1325 

60 West Fay Ave. 

Addison, IL 60101 

www.elmed.com 

ELMED INCORPORATED has been serving the 

Medical Profession since 1955. We will be introducing 

the “Jacubian” Cardio-Vascular Occluder 

Clamp – Maximum occlusion at 

minimum trauma. Featuring Endoscopic Cardiothoracic 

Instruments and the all new 

ELMED “Strong-Arm Retractor System for the 

MICS CABG procedure along with the traditional 

Retract-Robot, the most versatile retractor 

system. 

Elsevier Inc. 1304 

1600 JFK Blvd. , Ste 1800 

Philadelphia, PA 19103 

www.us.elsevierhealth.com 

ELSEVIER is a leading publisher of health science 

publications, advancing medicine by delivering 

superior reference information and 

decision support tools to doctors, nurses, health 

practitioners and students. With an extensive 

media spectrum — print, online and handheld, 

we are able to supply the information you need 

in the most convenient format. 

Enova Illumination 1036 

1839 Buerkle Rd 

St Paul, MN 55110 

ESTS 426 

1 The Quadrant, Wonford Road 

Exeter, EX2 4LE UK 

www.ests.org 

ESTS is the largest international general thoracic 

surgery organization with over 1300 members 

from all Continents. Our mission is to 

improve quality in our specialty: from clinical 

and surgical management of patients to education, 

training and credentialing of thoracic surgeons 

worldwide. 

Ethicon Endo-Surgery 1204 

4545 Creek Road 

Cincinnati, OH 45242 

www.ethicon.com 

The ETHICON brand is used for the products of 

Ethicon, Inc. and Ethicon Endo-Surgery, Inc., 

two companies with long histories of medical 

innovation, which provide globally a broad 

range of surgical technologies and products 

used to treat colorectal and thoracic conditions, 

women’s health conditions, hernias, cancer and 

obesity. 

Experimental Surgical Services 621 

420 Delaware St. SE MMC 220 

Minneapolis, MN 55455 

www.ess.umn.edu 

Experimental Surgical Services as the University 

of Minnesota is more then just a contract research 

organization. From discovery to 

regulatory strategy to submission we are the industry 

leader in research and testing rep-clinical 

medical devices and surgical techniques. 

Fehling Surgical Instruments, Inc. 718 

509 Broadstone Lane 

Acworth, GA 30101 

www.fehlingsurgical.com 

FEHLING SURGICAL features the “CERAMO® 

Instrument Line”, “SUPERPLAST Probes” and 

new innovative Retractor Systems for Minimally 

Invasive Cardiac Surgery. CERAMO® surface 

means high efficiency through enhanced performance, 

increased endurance and minimal 

maintenance. 

G & N Medical 518 

Maydwell Ave, Off Stane St. 

Horsham, 91902 UK 

www.gandn.com 

G & N Medical is a British medical device manufacturer 

and distributor. Having gained its regulatory 

approvals, the new patented sternal 

closure device ThorAcc® was launched in Europe 

in September 2012. Following successful 

evaluation in Boston, MA and elsewhere, the 

device is being introduced to US surgeons at 

this year's Meeting. 

Genesee BioMedical, Inc. 1624 

1308 South Jason Street 

Denver, CO 80223-3408 

www.geneseebiomedical.com 

Design Beyond Standard. Genesee BioMedical, 

Inc. provides unique devices for cardiothoracic 

surgery including sternal/thoracic 

valve retractors, instruments for MICS, coronary 

graft markers, suture guards, retraction 

clips and myocardial needles. All products 

are CE approved. 

Gore & Associates, Inc. 535 

960 W. Elliot Rd 

Tempe, AZ 85284 

www.goremedical.com 

The Gore Medical Products Division has provided 

creative solutions to medical problems for 

three decades. Over 35 million Gore Medical 

Devices have been implanted worldwide. Products 

include vascular grafts, endovascular and 

interventional devices, surgical materials, and 

sutures for use in vascular, cardiac and general 

surgery. For more information, visit 

http://www.goremedical.com. 

Haemonetics Corp. 430 

400 Wood Road 

Braintree, MA 2184 

www.haemonetics.com 

Haemonetics is a global healthcare company 

dedicated to providing innovative blood management 

solutions for our customers. Our devices, 

consumables, IT products, and 

consulting services deliver a suite of business 

solutions to help our customers improve clinical 

outcomes and reduce the cost of healthcare for 

blood collectors, hospitals, and patients around 

the world. 

Heart Hugger/ 

Gen'l Cardiac Technology 644 

15814 Winchester Blvd., #105 

Los Gatos, CA 95030 

www.hearthugger.com 

Heart Hugger-Sternum Support Harness is a 

patient operated support harness applied postop 

to splint surgical wounds. Benefits include 

improved patient compliance, faster return to 

premorbid respiratory levels, fewer wound complications 

and better post-op mobility. It is useful 

for post open-heart, thoracotomy, fractured 

rib and other chest trauma patients. 

HeartWare, Inc 434 

205 Newbury St. 

Framingham, MA 1701 

www.heartware.com 

HeartWare is dedicated to delivering safe, highperforming 

and transformative therapies that 

enable patients with heart failure to get back to 

life. The company’s breakthrough innovations 

begin with the HVAD® Pump, designed to be 

implanted in the pericardial space avoiding the 

more invasive surgical procedures required with 

older LVAD technologies. The HVAD Pump is 

commercially available around the world. 

I-Flow, LLC, a Kimberly-Clark 

Health Care Company 419 

20202 Windrow Dr. 

Lake Forest, CA 92630 

www.iflo.com 

I-Flow, LLC, a Kimberly-Clark Health Care Company, 

is the manufacturer of the non-narcotic, 

ON-Q* Pain Relief System, and is a global market 

leader in acute pain and ambulatory medication 

delivery, driving innovative clinical 

applications for surgical procedures and regional 

anesthesia for better outcomes and satisfied 

patients. For more information, visit 

www.iflo.com. 

Integra Lifesciences 1234 

311 Enterprise Drive 

Plainsboro, NJ 8536 

www.integralife.com 

Integra is a leader in Acute Care Surgical Products. 

The company’s portfolio includes quality 

instrumentation solutions for your sterile processing 

and OR needs in laparoscopic, general, 

cardiovascular, neuro, plastic and reconstructive 

surgery. Products include Luxtec® illumination 

systems and cables, instruments from 

Jarit®, Redmond, Padgett ®, Omni-Tract® 

table-mounted retractors and CIMS® Consulting 

Services. 

International Society of Minimally Invasive 

Cardiothoracic Surgery 935 

500 Cummings Center, Suite 4550 

Beverly, MA 1915 

www.ismics.org 

ISMICS is the leader in Innovation, Technologies, 

and Techniques in Cardiothoracic and Cardiovascular/Vascular 

Surgery. 2013 ISMICS 

Annual Scientific Meeting, 12-15 June 2013, 

Hilton Prague, Prague, Czech Republic, www.ismics.org. 

Intuitive Surgical, Inc. 1033 

1266 Kifer Rd, Bldg 101 

Sunnyvale, CA 94086 

www.intuitivesurgical.com 

Intuituve Surgical is the global leader in minimally 

invasive, robotic-assisted surgery. The 

Company's da Vinci® System- with 3D-HD vision 

and EndoWrist® instrumentation-enables 

surgeons to offer a minimally invasive approach 

for complex conditions. With da Vinci heart and 

lung surgery patients typically avoid the large 

incision and rub-spreading of open surgery 

IsoRay Medical 743 

350 Hills St, Suite 106 

Richland, WA 99354 

www.isoray.com 

IsoRay Medical offers radiation therapy 

(brachytherapy) products for the treatment of 

prostate, brain and lung cancers, among others. 

IsoRay’s FDA-cleared cesium-131 mesh implant 

is applied to the staple line following resection 

of Stage I NSCLC. The 9.7 day half-life 

of cesium-131 guarantees dose delivery six 

times faster than iodine-125 implants. 

Kapp Surgical Instrument Inc. 1334 

4919 Warrensville Center Rd. 

Cleveland, OH 44128 

www.kappsurgical.com 

Kapp Surgical is a custom design shop which 

designs surgical instruments and implants, 

manufactures them, and sells as well as distributes 

domestically and internationally. Kapp’s 

exclusive products are: The Cosgrove Heart Retractor, 

Bariatric Ring, Strip T’s surgical organizer, 

and countless surgical devices all FDA 

approved with several pending approvals.(Kapp 

owns 39 patents) 

Karl Storz Endoscopy-America, Inc. 1525 

2151 E. Grand Ave 

El Segundo, CA 90245 

www.karlstorz.com 

KARL STORZ, a leader in endoscopic equipment 

and instruments, offers solutions for 

video-assisted thoracic surgery (VATS). Our EndoCAMeleon® 

Laparoscope enables surgeons 

to adjust the viewing direction from 0° to 120° 

throughout procedures without changing laparoscopes. 

And our Video Mediastinoscopes with 

DCI®-D1® Camera allow video recording while 

working under direct vision. 

KLS Martin, LP 742 

PO Box 16369 

Jacksonville, FL 32245 

www.klsmartinnorthamerica.com 

KLS-Martin, a responsive company, is focused 

on the development of innovative products for 

oral, plastic and craniomaxillofacial surgery. 

New product developments in our titanium osteosynthesis 

plating systems allow these products 

to be used for rapid sternal fixation and 

reconstruction. 

Lexion Medical 843 

109 Preston Court 

Macon, GA 31210 

www.lexionmedical.com 

LEXION Medical, a leader of innovative medical 

technologies improving patient safety, offers humidified 

warm gas via the Insuflow® Gas Conditioning 

System for all thoracic and abdominal 

laparoscopic procedures, VesselGuardian® for 




desiccation free saphenous vein harvesting and 

PneuVIEW®XE Smoke Elimination System. 

AATS Annual 

Meeting Mobile App 

ow available 

Nthrough 

iTunes store, Android 

Market, and 

the AATS website, 

the 2013 AATS 

Annual Meeting 

Mobil App offers 

attendees the full 

AATS meeting experience. 

LifeNet Health 1335 

1864 Concert Dr 

Virginia Beach, VA 23453 

Lippincott Williams & Wilkins 508 

2 Commerce Sq, 2001 Market Street 

Philadelphia, PA 19103 

www.lww.com 

Lippincott Williams & Wilkins, a Wolters Kluwer 

Health company, is a leading international publisher 

of medical books, journals, and electronic 

media. We proudly offer specialized publications 

and software for physicians, nurses, students 

and clinicians. Please visit our booth to 

browse our comprehensive product line. 

LoupeCam 1034 

23623 N. Scottsdale Road D 3256 

Scottsdale, AZ 85255 

www.loupeCam.com 

HD Video Recording Camera Solutions for Surgical 

Loupes & Headlights. Finally, Surgical HD 

Video Recording has never been easier and accessible 

for under 5K. USB Footpedals offer a 

complete control over the camera and MegaPixel 

Lenses guarantee the needed Magnification. 

USB Plug and Play for Hands-On Surgeons. 

LSI Solutions 842 

7796 Victor-Mendon Road 

Victor, NY 14564 

www.lsisolutions.com 

COR-KNOT® delivers instant security with automated 

knotting and integrated suture trimming 

in one easy step. COR-KNOT® may 

reduce cardiopulmonary bypass and crossclamp 

time in your OR. Visit LSI SOLUTIONS® 

at booth 842 and see the newest edition to the 

COR-KNOT® family, the CK® Standard. 

MAQUET Medical Systems, USA 1607 

45 Barbour Pond Road 

Wayne, NJ 7470 

www.maquet.com 

MAQUET Medical Systems, USA is a global 

market leader offering a comprehensive portfolio 

of products designed for use in the Hybrid OR, 

ICU, Cath Lab and Cardiovascular Therapies. 

Market Access Partners 1435 

3236 S. Meadow View Road 

Evergreen, CO 80439 

www.marketaccesspartners.com 

Market Access Partners provides market research 

consulting to the medical device and 

pharmaceutical industries. We use innovative 

qualitative and quantitative methodologies to 

research opinions of physicians, nurses and patients. 

We offer a management orientated approach 

to product development and marketing. 

Mayo Clinic and 

University of Minnesota 507 

200 1st Street SW 

Rochester, MN 55905 

www.mayoclinic.org 

Mayo Clinic and University of Minnesota present 

Healing the Heart, a heritage of innovation 

exhibit. This display brings together, for the 

first time, two of the original heart-lung bypass 

circuits that helped set the world standard for 

open heart surgery. These institutions serve patients 

and advance science throughout the 

United States and around the world. 

Medafor Inc. 513 

2700 Freeway Blvd. Suite 800 


www.medafor.com 

Medafor’s patented technology, Microporous 

Polysaccharide Hemospheres (MPH®) provides 

a unique solution for adjunctive hemostasis in 

surgical applications. Arista® with MPH is a 

surgically-indicated, plant-based hemostat, providing 

an all-natural way to accelerate the 

body’s intrinsic clotting cascade with no inherent 

risk of adverse events. 

Medical Concepts Europe 545 

1083 Delaware Ave 

Buffalo, NY 14209 

www.medicalconcepts.eu 

MCE provides complete solutions for temporary 

pacing. Advanced design of temporary pacing 

leads and FastLockSingle Ude Interconnect Cables 

increase reliability and efficacy of pacing 

while reducing potential bleeding. Bipolar and 

Pediatric leads are available. 

Medistim 1519 

14000 25th Ave. N. Ste. 108 

Plymouth, MN 55447 

Medpace Medical Device 1038 

5375 Medpace Way 

Cincinnati, OH 45227 

www.medpace.com/devices 

Medpace Medical Device, MMD, is a division of 

Medpace exclusively dedicated to the design 

and conduct of medical device trials and offers 

global support for in over 40 countries. The division 

is led by device experts highly knowledgeable 

about international regulatory 

requirements, i.e. FDA and EMA regulations. 

Medtronic Inc. 605 

710 Medtronic Parkway 


www.medtronic.com 

Find Opportunity in Change and consider 

Medtronic’s intuitive solutions in structural 

heart and aortic diseases including: tissue, mechanical 

and transcatheter valves; irrigated RF 

and cryo surgical ablation devices; aortic stent 

graft systems; and OPCAB, MICS CABG, cannulae 

and perfusion products. 

NeoChord 538 

7700 Equitable Drive, Suite 206 

Eden Prairie, MN 55344 

www.neochord.com 

NeoChord's CE Marked device enables beating 

heart, sternal sparing impantation of neochordae 

and allows real time echo feedback of MR 

correcting. The company is also developing 

NeoNav, an "augmented reality" device navigation 

technology for mitral procedures. Caution: 

The NeoChord device in not available for commercial 

use in the U.S. 

Nordson MICROMEDICS 1229 

1270 Eagan Industrial Road 

St. Paul, MN 55121 

www.nordsonmicromedics.com 

Micromedics is the partner of choice to the 

healthcare industry for custom biomaterial delivery 

solutions and provides innovative product 

development and design expertise, comprehensive 

global regulatory support, and broad manufacturing, 

assembly and packaging capabilities. 

For over 25 years, Micromedics has developed 

and manufactured quality, single-use devices for 

optimal delivery of single- and multi-component 

liquid biomaterials. Visit us in booth 1229. 

Olympus Medical Systems Group 1730 

3500 Corporate Parkway, POB 610 

Center Valley, PA 18034-0610 

www.olympusamerica.com 

Olympus offers the newest, most versatile video 

system, EVIS EXERA III. Compatible with any 

Olympus scope, rigid of flexible, this universal 

platform can be used with the EndoBronchial 

UltraSound(EBUS) bronchoscope and ViziShot, 

EBUS-TBNA, aspiration needle system. Integrate 

further with ENDOALPHA , and control 

your OR equipment from a single touch screen. 

On-X Life Technologies, Inc. 1129 

1300 E. Anderson Lane, Building B 

Austin, TX 78752 

www.onxlti.com 

On-X® Heart Valves and MV Chordal Repair: 

Patented natural design and On-X® Carbon offer 

reduced turbulence in a mechanical valve to 

rival the clinical and hemodynamic performance 

of bioprostheses. FDA IDE approved 

PROACT (Prospective Randomized On-X® Anticoagulation 

Clinical Trial) is in process. Chord-X 

ePTFE Suture for MV chordae tendineae repair. 

Orascoptic Research 1424 

3225 Deming Way 

Middleton, WI 53562 

www.orascoptic.com 

Orascoptic designs and manufactures high-performance 

magnification loupes for dentists, hygienists 

and other dental professionals. 

Renowned for quality craftsmanship, Orascoptic 

loupes deliver remarkable resolution over a 

deep and wide viewing field. Superior visualization 

is achieved through innovative, lightweight 

optics made from only the finest grade of glass. 

With six different telescopes models to choose 

from, each available on a variety of frame styles 

and colors, Orascoptic offers one of the most 

comprehensive portfolios of magnification eyewear 

in the healthcare industry. 

Oscor Inc. 1115 

3816 DeSoto Blvd 

Palm Harbor, FL 34683 

www.oscor.com 

Oscor is a leading manufacturer of permanent 

and temporary Cardiac Pacing and Stimulation 

Leads, External Pacemakers, Peel Away and 

Hemostatic valved Introducers, Transseptal 

Guiding Sheaths, Guiding Catheters, Diagnostic, 

Angiography and Balloon Catheters. Typical 

products are Pacing and Stimulation Leads, Introducers, 

Adaptors, Catheters and Shaft Assemblies. 

FDA registered. ISO 13485:2003 

certified. 

Oxford University Press 1343 

198 Madison Ave 


www.oup.com 

OUP publishes some of the most respected 

medical books and journals in the world, including 

the renowned trio of journals from the 

European Association for Cardio-Thoracic 

Surgery. Come and visit our stand to browse 

books and pick up journal sample copies. 

Pemco Inc. 1529 

5663 Brecksville Road 

Cleveland, OH 44131-1593 

Péters Surgical 1528 

42, Rue Benoit Frachon 

Bobigny cedex, 93000 France 

www.peters-surgical.com 

Péters Surgical develops, manufactures and 

distributes medical devices worldwide. This 

French company was founded in 1926 and has 

continued to grow. Today Péters Surgical has 

four operating locations all maintaining a high 

standard of quality and service. Offering specialized 

cardiac suture brands Corolene, Cardioxyl, 

Cardionyl, and now introducing 

Cardioflon Evolution. 

Pfizer Pharmaceuticals 413 

235 E. 42nd St, 219 7 1 


Philips Medical Systems 1836 

22100 Bothell-Everett Highway 

Bothell, WA 98021 

www.philips.com/hybridOR 

TAVI procedures require high quality imaging 

and workflow planning for device placement. 

The Philips TAVI Suite takes integration to the 

next level with its advanced imaging tools such 

as HeartNavigator for procedure planning and 

live image guidance and EchoNavigator, which 

combines Live 3D TEE with fluoroscopy for enhanced 

visualization of complex anatomy. 

Pioneer Surgical Technology 1610 

375 River Park Circle 

Marquette, MI 49855 

www.pioneersurgical.com 

Pioneer Surgical proudly offers Tritium SCP, an 

FDA cleared sternal cable plating system. Complementing 

their current cable system, Tritium 

provides more options to surgeons and addresses 

varying patient anatomies. Pioneer is a leading 

innovator in the design and manufacturing 

of implants and instruments used for chest closures 

following median sternotomies. 

Qualiteam s.r.l. 1238 

Casale Nassio Sopra 15A 

Chiaverano TO, 10010 Italy 

www.qualiteam.com 

Qualiteam develops, manufactures and distributes 

unique products gentle to the human body 

with focus on patient comfort and functional 

convenience for staff. Come visit our booth for 

an in-depth look at how our products could 

help your patients recover sooner and ultimately 

decrease the costs of cure. 

Quest Medical Inc. 634 

One Allentown Parkway 

Allen, TX 75002-4211 

www.questmedical.com 

Quest Medical, Inc. is a medical device manufacturer 

and worldwide distributor specializing 

in protecting the heart during cardiac surgery 

with the Quest MPS 2® and Microplegia. Quest 

also offers a unique variety of aortic punches, 

safety valves, vascular loops, and an anesthesia 

line designed for optimum cardiovascular 

surgery. 

Richard Wolf Medical 

Instruments Corp. 1511 

353 Corporate Woods Parkway 

Vernon Hills, IL 60061 

www.richardwolfusa.com 

Richard Wolf offers complete solutions for minimally 

invasive diagnostic and operative applications 

including bronchoscopy, thoracoscopy, 

esophagoscopy and mediastinoscopy. 

Rose Micro Solutions 942 

4105 Seneca Street 

West Seneca, NY 14224 

Rultract 1529 

5663 Brecksville Road 

Cleveland, OH 44131-1593 

www.rultract.net 

Rultracts'’ surgical retractor provides gentle and 

uniform lift allowing maximum exposure for 

IMA dissection, re-do hearts, xiphoid entry, subxiphoid 

pericardial procedures, minimally invasive 

procedures (capable for use with 

Thoratrak), Parasternal procedures, 

Pediatric/ASD, T-incisions, Trans-Abdominal 

GEA midcab, Pectus, TEMLA, VAMLA, MICS, 

CABG, LVAD and Pectus Excavcatum NUSS 

Repair. 

Sanofi Biosurgery 837 

55 Cambridge Parkway 

Cambridge, MA 2142 

www.sanofi.us 

Sanofi Biosurgery is a global strategic business 

unit of Sanofi. It develops and markets innovative, 

biologically based products for osteoarthritis 

relief, adhesion prevention, temporary 

endovascular occlusion of blood vessels, cartilage 

repair, and severe burn treatment. Sanofi 

Biosurgery is committed to transforming disease 

management through innovative medical 

interventions. 

Scanlan International, Inc. 1205 

One Scanlan Plaza 

St. Paul, MN 55107 

www.scanlaninternational.com 

Highest quality surgical products designed and 

manufactured by the Scanlan family since 

1921. Over 3000 titanium and stainless steel 

precision instruments including: VATS/MIS thoracoscopic 

instruments, Scanlan® SUPER 

CUT Scissors, and Scanlan® LEGACY titani-



um needle holders and forceps. Single-use 

products include Aorta/Vein Punches, VASCU- 

STATT® bulldog clamps and graft markers. 

Siemens Healthcare 1736 

51 Valley Stream Parkway 

Malvern, PA 19355 

www.usa.siemens.com/surgery 

The Siemens Healthcare Sector is one of the 

world's largest suppliers to the healthcare industry 

and a trendsetter in medical imaging, 

laboratory diagnostics, medical information 

technology and hearing aids. With over 150 installations 

in US (over 300 worldwide), 

Siemens is a leading provider of imaging systems 

for the Hybrid OR. 

Society for Heart Valve Disease 937 

500 Cummings Center, Suite 4550 

Beverly, MA 1915 

www.shvd.org 

The SHVD, which promotes research and education 

regarding the causes, prevention, and 

treatment of heart valve disease, is comprised 

of individuals dedicated to improving heart 

valve disease in the global population, including 

cardiologists, cardiothoracic surgeons, researchers, 

allied health professionals, students, 

and institutional representatives. The Society 

holds biennial meetings in conjunction with the 

Heart Valve Society of America (HVSA). 

Society of Thoracic Surgeons 404 

633 N St Clair 

Chicago, IL 60611 

www.sts.org 

The Society of Thoracic Surgeons represents 

more than 6,400 surgeons, researchers, and allied 

health care professionals worldwide who 

are dedicated to ensuring the best possible outcomes 

for surgeries of the heart, lung, and 

esophagus, as well as other surgical procedures 

within the chest. The Society offers a wide variety 

of member benefits, including reduced participation 

fees in the renowned STS National 

Database, a complimentary subscription to the 

prestigious Annals of Thoracic Surgery, dynamic 

educational offerings, online patient information 

resources, and much more. Stop by booth 

#404 or visit the STS website, www.sts.org, to 

learn more about The Society of Thoracic Surgeons 

Sontec Instruments Inc. 405 

7248 South Tucson Way 

Centennial, CO 80112 

www.sontecinstruments.com 

Sontec offers headlights and loupes and the 

most comprehensive selection of exceptional 

hand held surgical instruments available to the 

discriminating surgeon. There is no substitute 

for quality, expertise and individualized service. 

Sontec's vast array awaits your consideration at 

our booth. 

Sorin Group 1019 

14401 W. 65th Way 

Arvada, CO 80004 

www.sorin.com 

Sorin Group is a world leader in the treatment 

of cardiovascular diseases. Our innovative product 

portfolio includes aortic and mitral valve replacement 

and repair, perfusion equipment, 

cannula and MICS instruments. For more information 

visit our web site at www.sorin.com. 

Visit OR/ICU of the Future in 

the Exhibit Hall 

he “Operating Room of the Fu- 

Hybrid Technologies, CT 

Tture: 

ICU of the Future, and TAVI 

Suites” exhibit features state-of-theart 

innovations in postoperative 

care and technology. The display of 

multidisciplinary, multifunctional 

rooms opened on Sunday at 5:00 

p.m. in the Exhibit Hall. 

Spec-Med 1214 

113 Teal St. 

St. Rose, LA 70087 

www.spec-med.com 

St. Jude Medical, Inc. 719 

6300 Bee Cave Road Bldg 2 Ste 100 

Austin, TX 78746 

www.sjm.com 

St. Jude Medical’s history of commitment to 

cardiac surgery continues with our legacy of 

market-leading heart valves, which continues 

our passion of putting more control into the 

hands of physicians to offer patients an improved 

quality of life. 

STS Advocacy Center 408 

633 N. St Clair 

Chicago, IL 60611-3658 

www.sts.org 

The STS Advocacy Center Booth #408 is the 

best place to learn about STS government relations 

activities and to find out how you can 

help your practice and the future of the specialty. 

Stop by Booth #408 where you can receive 

timely information on federal legislation and 

regulations impacting your practice, obtain 

tools to engage members of Congress, and 

learn about how to become a Key Contact for 

cardiothoracic surgery. 

Sunshine Heart 619 

12988 Valley View Road 

Eden Prairie, MN 55344 

www.sunshineheart.com 

The C-Pulse Heart Assist System is a CE 

Marked extra-aortic balloon pump using counterpulsation 

technology to treat Class III/Class 

IVa Heart Failure. It is placed outside the 

bloodstream, can be performed minimally invasively, 

and can be disconnected. It improves 

heart function by, increasing coronary blood 

flow, decreasing afterload and increasing cardiac 

flow. 

superDimension, Inc. 542 

161 Cheshire Lane, Ste 100 


www.superdimension.com 

superDimension, Inc. develops and manufactures 

software, hardware and disposables for 

the lung disease market. superDimension’s 

iLogic system is the total bronchial access and 

navigation system that provides a safe pathway 

to peripheral or central lung lesions, even for 

patients with procedure-restricting conditions. 

Surge Cardiovascular / 

MED Alliance Solutions, LLC 1534 

3825 Commerce Drive 

St. Charles, IL 60174 

www.surgecardiovascular.com 

Surge Cardiovascular designs, develops, manufactures, 

and markets a wide range of open 

heart surgical products for cardiothoracic procedures. 

The company serves commercial acute 

care hospitals, federal government facilities, 

and provides OEM operations. The Surge Cardiovascular 

portfolio is CE Marked and distributed 

across North America, South America, 

Europe, and Asia. 

Surgical Acuity, Inc. 638 

3225 Deming Way 

Middleton, WI 53562 

Surgitel/General Scientific Corp 1328 

77 Enterprise Drive 

Ann Arbor, MI 48103 

SurgiTel Systems is dedicated to offering the 

best in ergonomics, vision, and comfort. Coupling 

SurgiTel Systems' High Definition Optics 

with Oakley Frames, we offer the very best in 

magnification systems. SurgiCam, our loupemounted 

camera system, is digital and lightweight 

allowing the viewers to see images at 

the user’s perspective. 

SynCardia Systems, Inc. 943 

1992 E Silverlake Drive 

Tucson, AZ 85713 

www.syncardia.com 

The SynCardia temporary Total Artificial Heart 

(TAH-t) is the world’s only FDA, Health Canada 

and CE approved Total Artificial Heart. It is approved 

as a bridge to transplant for patients dying 

from end-stage biventricular failure. Visit 

our booth for updates on the Freedom 

portable driver, 50cc TAH-t and destination 

therapy. 

Teleflex Medical 1128 

2917 Weck Rrive 

Durham, NC 27709 

www.teleflex.com 

The Teleflex portfolio offers today’s cardiothoracic 

surgeon comprehensive resources including: 

Horizon, Hemo-clip® ligation, 

Hem-o-lok®, Tevdek®, Deklene® Maxx suture, 

Pleur-evac® chest drainage. Weck, Deknatel, & 

Pilling are recognized pioneer companies providing 

cardiovascular products enhancing patient 

outcomes. 

Terumo Cardiovascular Systems 919 

6200 Jackson Road 

Ann Arbor, MI 48103 

Thompson Surgical Instruments, Inc. 423 

10170 East Cherry Bend Road 

Traverse City, MI 49684 

www.thompsonsurgical.com 

Thompson Surgical is the original manufacturer 

of table-mounted retractors .The Bolling Mitral 

Valve Retractor System is a result of an extensive 

collaboration with Dr. Stephen Bolling, an 

internationally renowned cardiac surgeon; offering 

low profile handles that are never in the 

way and the frame and handles do not interfere 

with sutures. The Bolling Retractor provides uncompromised 

exposure for a variety of procedures 

including Trans Septal Approach, Direct 

Atrial Approach, Mitral Valve Repair, Mitral 

Valve Replacement and MAZE. 

Thoracic Surgery Foundation for Research 

and Education 1105 

633 N. St Clair 

Chicago, IL 60611 

www.tsfre.org 

TSFRE was established in 1988 as a 501c(3) 

not-for-profit charitable organization by the four 

leading thoracic surgery societies: AATS, STS, 

STSA, and WTSA. TSFRE’s mission is to foster 

the development of surgeon scientists in cardiothoracic 

surgery; increasing knowledge and 

innovation to benefit patient care. 

Thoramet Surgical Products 944 

301 Route 17 N, Suite 800 

Rutherford, NJ 7070 

www.thoramet.com 

The Surgeon’s choice for VATS instrumentation! 

We offer the most extensive catalog of pure thorascopic 

patterns available anywhere. The feel 

you want, the actuation you need, the patterns 

you demand! Come see our unique versatility 

and new instruments! 

Thoratec Corporation 504 

6035 Stoneridge Drive 

Pleasanton, CA 94588 

www.thoratec.com 

Thoratec is the world leader in mechanical circulatory 

support with the broadest product portfolio 

to treat the full range of clinical needs for 

patients suffering from advanced heart failure. 

Thoratec’s products include the HeartMate 

LVAS, Thoratec VAD, CentriMag and PediMag / 

PediVAS. 

Transonic Systems Inc. 1139 

34 Dutch Mill Rd. 

Ithaca, NY 14850 

www.transonic.com 

What do you routinely think about when you're 

leaving the O.R.? Are you hoping that the grafts 

you just placed are patent after reversing anticoagulation? 

Obtain peace of mind by measuring 

blood flow just prior to approximation with 

Transonic transit-time ultrasound flow measurement 

technology. 

USB Medical, Ltd. 642 

2000 Pioneer Road 

Huntingdon Valley, PA 19006 

Valves of Heart, Inc. 422 

120 E 87th Street, Unit R14 B 


Vitalcor, Inc. 1111 

100 E. Chestnut Avenue 

Westmont, IL 60559 

www.vitalcore.com 

Latex Free Coronary Artery Balloon Canulae 

with self-inflating Balloon (3-year shelf life). 

Reusable Dingo (Bulldog) Clamp. Titanium and 

stainless steel specialty instruments and retractors. 

Reusable stabilizer for Beating Heart 

Surgery and Mitral Valve Retractor. 

Vitalitec 1413 

10 Cordage Park Circle, Suite 100 

Plymouth, MA 2360 

www.vitalitec.com 

Vitalitec Geister will be displaying all our products, 

highlighting our Enclose® II Anastomosis 

Assist Device, Cygnet® Flexible Clamps, Intrack® 

Atraumatic Temporary Clamps and Inserts 

and Geister® ValveGate® and Valvegate® 

PRO line of MIS CV instrumentation. You may 

view out products at www.vitalitec.com and 

www.geister.com prior to visiting at our booth. 

Wake Forest/ 

Preclinical Surgical Services 442 

200 East First Street 

Winston-Salem, NC 27101 

www.wakepreclinicalservices.com 

Preclinical Surgical Services is a full-service 

CRO focusing on proof-of-principle, method development, 

and efficacy testing in the preclinical 

medical technology research arena. 

Pre-surgical bench analysis, ex-vivo modeling, 

dynamic imaging and surgical models in all 

specialties. From concept to clinical applications, 

PSS is your innovation partner. 

Wexler Surgical 527 

11333 Chimney Rock Road, #110-120 

Houston, TX 77035 

www.wexlersurgical.com 

Wexler Surgical designs and manufactures a variety 

of titanium and stainless steel specialty 

surgical instruments and products for Cariac, 

Vascular, Thoracic, and Micro Surgery. Come 

see our new VATS/MICS instruments and ask 

about out Optimus Series. Visit us online at 

www.wexlersurgical.com for more information 

about our products and the services. 

World Society for Pediatric and Congenital 

Surgery 439 

2300 Tupper St. C8-29 

Montreal, QC H3H1P3 Canada 

www.wspchs.org 

The mission of the World Society for Pediatric 

and Congenital Heart Surgery is to promote the 

highest quality comprehensive cardiac care to 

all patients with congenital heart disease, from 

the fetus to the adult, regardless of the patient’s 

economic means, with an emphasis on 

excellence in teaching, research and community 

service. 

Worldwide Trends 1507 

2120 Prospect St 

Menlo Park, CA 94025 

Worldwide Trends is a network of experienced 

market professionals working with medical device 

global companies. 

AATS Exhibit Additions 

Cadence Pharmaceuticals 437 

7436 West Shore Drive 

Edina,MN 55435 

www.cadencepharm.com 

Cadence Pharmaceuticals, Inc. offers Ofirmev 

(acetaminophen) injection 1000 mg/100 mL 

(10mg/mL). Ofirmev is indicated for the management 

of mild to moderate pain; the management 

of moderate to severe pain with adjunctive 

opioid analgesics; and the reduction of fever. 




GE Healthcare 638 

9900 Innovation Dr. 

Wauwatosa, WI 53103 

www.gehealthcare.com 

GE is making a new commitment to health. 

Healthymagination will change the way we approach 

healthcare, with more than 100 innovations 

all focused on addressing three critical 

needs: lowering costs, touching more lives and 

improving quality. 

Grifols Inc. 1513 

4101 Research Commons, 

79 T.W. Alexander Drive 

Research Triangle Park, NC 27709 

www.thrombate.com 

Grifols is a multinational pharmaceutical and 

chemical company. Principally a producer of 

blood plasma-based products and also supplies 

devices, instruments and reagents for clinical 

testing laboratories. Product description for 

Thrombate can be found on 

www.thrombate.com. 

Lifelike Biotissue 1614 

700 Collip Circle 

London, Ontario, Canada 

www.lifelikebiotissue.com 

Mesocare.org 530 

440 Louisiana #1212 

Houston TX 77002 

www.mesocare.org 

Our mission at Mesocare.org is to empower 

mesothelioma patients, family members, and 

caregivers through education about the disease 

and its treatment and through awareness of the 

services and resources available to them wherever 

they may live. The stakes in the battle 

against this cancer are high, and we hope that 

we provide everyone with access to the most 

current and accurate information available. 

St. Cloud Hospital 1538 

1406 6th Ave. N 

St. Cloud , MN 56303 

www.centracare.com 

Experts Featured in General Thoracic Symposium 

The General Thoracic Surgery 

Symposium featured talks on 

topics ranging from stage 1 

non–small cell lung cancer 

(NSCLC), to esophageal anastomosis, 

to the use of VAC negative pressure 

wound therapy for complicated 

infections. 

With tuberculosis an increasing 

problem in the modern world, John 

Mitchell, MD, reviewed treatment 

strategies for tuberculosis patients, 

mainly those with multi-drug-resistant 

infection, who are referred for 

surgery. Dr. Mitchell, of the University 

of Colorado, said that surgical 

resection as an adjunct to medical 

therapy has shown benefits in multiple 

studies. Surgery is favored in 

patients with localized lung damage, 

including cavitation and destroyed 

tissue, that might be a focus 

of persistent disease in those who 

do not have access to or are intolerant 

of chemotherapy. 

“Lobectomy and pneumonectomy 

by means of a thoracotomy are 

the most commonly performed 

procedures, although a minimally 

Dr. Mitchell addressed the role of 

minimially invasive approaches to TB. 

invasive approach is feasible in 

some patients,” Dr. Mitchell said, 

pointing out that results can be 

good, with relatively low mortality 

rates (0%-5%) and greater than 90% 

sputum conversion being achievable. 

He also discussed the potential 

role of surgery in treating the rarer 

“nontuberculous mycobacteria” 

(NTM), ubiquitous environmental 

MARTIN ALLRED 

Dr. Lanuti pointed out the value of RFA 

for select, high-risk NSCLC patients. 

pathogens that can attack patients 

with damaged lungs or compromised 

immune systems and is often 

drug resistant. “Lung resection has 

been found to reduce relapse rates 

and to improve eradication of the 

infection by removing damaged areas 

of lung parenchyma,” Dr. 

Mitchell said. 

“Untreated stage I NSCLC has a 1- 

year survival rate of around 75% but 

MARTIN ALLRED 

survival rapidly declines to 50% by 9 

months, with very few patients alive 

5 years after the diagnosis,” said 

Massachusetts General Hospital’s 

Michael Lanuti, MD. 

Dr. Lanuti stressed the need for 

alternative treatments for those 

20%-30% of patients deemed ineligible 

or at high risk for the “gold 

standard” treatment, lobectomy. He 

discussed the role of radiofrequency 

ablation (RFA) and stereotactic 

body radiotherapy (SBRT) in their 

treatment. 

“RFA is a reasonable treatment for 

high risk stage I NSCLC patients 

who have peripheral lesions less than 

3 cm, but not for those patients who 

have lesions adjacent to major bronchovascular 

structures, or the esophagus,” 

he advised. Despite the lack of 

phase III trial data, SBRT is preferred 

for medically inoperable patients 

with peripheral T1/2N0 (less than 5 

cm) NSCLC, with a modified treatment 

for patients with tumors close 

to the bronchial tree,” Dr. Lanuti 

said. 

“Navigational bronchoscopy will 

continue to play a major role in diagnostics, 

especially with the development 

of improved biopsy instrumentation 

and catheters,” said Douglas 

Minnich, MD, of the University 

of Alabama, in his discussion of the 

foundations of the technique, its inerpretation 

and value. 

5” modified chest spreader retractor 

for either a proximal or distal 

mini-sternotomy procedure 

The universal lift is attached to the 

sternal retractor arm and is used to 

lift the patient’s left chest one to 

two inches 

Navigational broncoscopy has a firm 

future, said Douglas Minnich, MD. 

MARTIN ALLRED

Comprehensive Cardiovascular Care 

Terumo PROUDLY WELCOMES Nonin Medical’s 

EQUANOX Regional Oximetry System. 

® 

EQUANOX Model 7600 Regional Oximetry System 

For continuous, real-time cerebral and somatic perfusion 

monitoring during cardiac surgery and beyond, Nonin 

Medical’s EQUANOX Regional Oximetry System is the 

only cerebral/somatic tissue oximeter to use a dual light 

emitting and detecting sensor architecture for accuracy you 

can act on. Trust EQUANOX to help prevent brain and organ 

injury in your neonatal, pediatric and adult patients. 

www.terumo-cvs.com/regionaloximetry 

Manufactured by NONIN MEDICAL, INC. in Plymouth, MN. Distributed in 

the USA by Terumo Cardiovascular Systems, Ann Arbor, MI. 

Beating Heart Products 

Providing the most reliable, versatile and stable solution 

for cardiac bypass surgery. 

www.terumo-cvs.com/estech 

Manufactured by ESTECH in San Ramon, CA. Distributed in the USA by 

Terumo Cardiovascular Systems, Ann Arbor, MI. 

VirtuoSaph ® Plus Endoscopic Vessel Harvesting System 

Providing an endoscopic approach to vessel harvesting that, 

when used in conjunction with the ‘Terumo Method’ of vessel 

harvesting, consistently delivers bypass grafts with a new 

standard of care. 

www.terumo-cvs.com/virtuosaph_plus 

Vascutek ® Cardiovascular Grafts 

Offering a comprehensive portfolio of vascular grafts 

including the world’s only branched polyester grafts 

indicated for debranching and associated hybrid procedures. 

www.terumo-cvs.com/hybrids 

Manufactured by VASCUTEK, a TERUMO Company, in Renfrewshire, 

Scotland, UK. Distributed in the USA by Terumo Cardiovascular Systems, 

Ann Arbor, MI. 

Subject to local regulatory clearance. 

Please visit Terumo CVS at booth #919 during the 93rd AATS Annual Meeting for a closer look at our product lines. 

Terumo Cardiovascular Systems Corporation Ann Arbor, Michigan USA 734.663.4145 800.758.8000 

Terumo Corporation Tokyo, Japan 81.3.3374.8111 | Terumo Europe N.V. Cardiovascular Division Eschborn, Germany 49.61.96.8023.0 

Terumo Europe N.V. Leuven, Belgium 32.16.38.1211 | Terumo Latin America Corporation Miami, Florida USA 305.477.4822 

©2013 Terumo Cardiovascular Systems Corporation. Terumo® and VirtuoSaph® are trademarks of Terumo Corporation. EQUANOX is a registered trademark 

of Nonin Medical, Inc. Estech is a trademark of Endoscopic Technologies, Inc. Vascutek® is a registered trademark of Vascutek LTD. 835801


Honing Congenital Heart Skills for Difficult Cases 

Saturday’s AATS Congenital 

Skills and Decision-Making 

Course, chaired by Carl L. 

Backer, MD, of Children’s Memorial 

Hospital, provided a full day’s focus 

on tips and techniques for performing 

many of the most important congenital 

heart operations in today’s 

armementarium. 

There is considerable difference of 

opinion in the timing and techniques 

best used for treating asymptomatic 

Tetralogy of Fallot (TOF) with pulmonary 

valve (PV) replacement, according 

to Stephanie Fuller, MD, of 

Children’s Hospital. Criteria for valve 

replacement include increased right 

ventricle (RV) size, progressive or new 

tricuspid valve regurgitation, severity 

of pulmonary valve regurgitation, and 

the development of ventricular arrhythmias, 

according to Dr. Fuller. 

Unfortunately, despite widely varying 

opinion, and extensive literature 

review, although pulmonary valve insertion 

has been shown to demonstrate 

a decrease in RV size and a 

symptomatic benefit, it remains unclear 

whether there is a functional 

improvement, even for those patients 

with less significant RV dilation, said 

Dr. Fuller. 

John M. Costello, MD, reviewed 

neonatal congenital heart care. 

MARTIN ALLRED 

So, unfortunately, although abundant 

indications for intervention exist, 

no prospective data exist, leaving 

the optimal timing of PV replacement 

in the asymptomatic patient 

unknown. “With the development of 

percutaneous valve replacement, involving 

a much less invasive procedure, 

perhaps the criteria will shift to 

earlier and more aggressive valve replacement,” 

she speculated. 

Without compelling evidence, dogma 

can easily creep into medical care 

as assumed truth. John M. Costello, 

MD, of the Boston’s Children’s Hospital, 

called into question several 

common beliefs in neonatal congenital 

heart care including the optimal 

timing of delivery for neonates with 

critical congenital heart disease, the 

benefits of using of corticosteroids in 

cardiopulmonary bypass, and the 

benefits of tight glycemic control. 

Despite the fact that prematurity, 

defined as birth before 37 weeks’ gestation, 

is known to be a well-established 

risk factor for mortality in 

neonates with congenital heart disease, 

there have been little data on 

the optimal timing. The assumption 

has been that birth occurring at any 

time during the full-term period (i.e., 

37-42 weeks) is not considered a risk 

factor for adverse outcomes. However, 

a retrospective study of more 

than 900 neonates with critical congenital 

heart disease showed a significant 

U-shaped relationship between 

gestational age at birth and mortality 

with the lowest mortality (less than 

3%) occurring in patients born between 

39 and 40 weeks gestation. 

Hospital mortality was nearly 7% for 

those babies born at 37-38 weeks’ 

Stephanie Fuller, MD, discussed 

treatment of asymptomatic TOF. 

gestation and 8% for those babies 

born beyond 41 weeks. “Thus, in the 

absence of compelling maternal or 

fetal indications, elective delivery prior 

to 39 weeks’ gestation should be 

avoided,” advised Dr. Costello. 

In another area of assumed truth, 

despite early indications as to their 

benefits, further study of the use of 

corticosteroids has failed to show any 

Congenital on following page 

MARTIN ALLRED 

AATS 

FOCUS ON 

THORACIC 

SURGERY: 

ESOPHAGEAL 

DISEASE 

SAVE THE DATE 

AMERICAN ASSOCIATION 

FOR THORACIC SURGERY 

We Model Excellence 

PROGRAM DIRECTORS 

G. Alec Patterson, MD 

David J. Sugarbaker, MD 

PROGRAM COMMITTEE 

Thomas D’Amico, MD 

Shaf Keshavjee, MD 

James D. Luketich, MD 

Bryan F. Meyers, MD 

Scott J. Swanson, MD 

November 15 - 16, 2013 

Boston Marriott Copley Place 

Boston, MA, USA 

www.aats.org/esophageal


General Thoracic Skills from page 1 

placed to use and further evaluate 

the use of sterotactic body radiation 

therapy (SBRT) in patients with small 

peripheral lung cancers and no nodal 

or systemic spread. 

He pointed out that not only are 

there ongoing randomized trials 

which evaluated surgery versus 

SBRT in medically operable patients, 

but that SBRT delivery by thoracic 

surgeons is a now a billable procedure 

with its own CPT code established 

January 2013. This code 

defines thoracic surgeon involvement 

including tumor delineation 

and confirmation of target volume 

during delivery. 

“Thoracic surgeons are the best 

suited to assess operability in borderline 

patients and they are also best 

versed in invasive mediastinal staging, 

and as such should be strongly 

encouraged to participate in the 

treatment of patients with lung cancer 

with SBRT,” concluded Dr. 

Christie. 

The Ivor Lewis operation has been a 

mainstay of esophageal resection for 

decades and can be performed in both 

open and minimally invasive formats, 

Thoracic surgeons should evaluate use 

of SBRT, said Neil A. Christie, MD. 

according to Donald E. Low, MD, of 

Virginia Mason. After describing 

methodology for both open and minimally 

invasive surgery, he turned his 

attention to the importance of a multidisciplinary 

team to good outcomes. 

“Although careful and meticulous 

surgery will remain the single, individual, 

most critical factor affecting 

outcomes of esophageal resection, 

truly impacting the outcomes requires 

not only good surgery but also 

a diverse and multidisciplinary team," 

MARTIN ALLRED 

he said, describing how his institution 

established a standardized clinical 

pathway involving an entire clinical 

care team including anesthesiology, 

critical care, ward nursing, dietary, 

physical therapy, oncologic nurse coordinators 

and trainees. 

“Goal-directed therapy has provided 

a template for improving outcomes 

over time, including a 

mortality rate of under 1%, an anastomotic 

leak rate of under 4%, and a 

median length of stay currently under 

10 days,” he added. 

“It is important that surgeons take 

a leading role in the development of 

standardized clinical pathways and 

enhanced recovery programs so that 

surgery will remain an integral component 

in the treatment of early and 

locoregional esophageal cancer,” Dr. 

Low concluded. 

“Although transhiatal esophagectomy 

(THE) is a well-established procedure 

applicable to most patients 

requiring esophageal resection and reconstruction, 

a successful outcome requires 

close attention to technical 

details,” according to Mark B. Orringer, 

MD, of the University of 

Michigan. 

He described the five sequential 

A standardized clinical pathway is 

key, argued Donald E. Low, MD. 

phases of the transhiatal esophagectomy: 

the abdominal, cervical, mediastinal, 

conduit preparation and 

positioning, and cervical anastomosis, 

providing a list of unique potential 

pitfalls at each stage. 

For example, in the abdominal 

phase, these pitfalls included ischemic 

necrosis of the stomach from 

ligating short gastric vessels too 

closely and the indavertent division 

of an abberant left gastric artery, Dr. 

Orringer said. 

MARTIN ALLRED 

Congenital from previous page 

benefit in early outcomes after pediatric 

CPB in the current era and may 

be associated with greater infection 

risk. A current randomized, placebocontrolled 

study at the University 

Charles D. Fraser, MD, argued for 

close intraoperative neuromonitoring. 

MARTIN ALLRED 

Medical Center of South Carolina may 

finally answer this question for good. 

Similarly, the early positive findings 

of the initial benefits of tight perioperative 

glycemic control in both adult 

and pediatric trials have been challenged 

by more recent investigations, 

said Dr. Costello. In a recent randomized 

trial, of nearly 1,000 children less 

than 3 years of age undergoing cardiac 

surgery, no significant differences were 

found between the tight glycemic control 

and the standard treatment patients 

in health care associated 

infections or a variety of secondary 

oucomes. A multicenter European trial 

of tight glycemic control is underway, 

and the results should clarify the 

issue further. “But given the costs and 

difficulty of monitoring, currently, the 

available evidence doesn’t as yet support 

tight glycemic control as standard 

practice after pediatric cardiac 

surgery,” Dr. Costello concluded. 

Children born with congenital heart 

disease requiring surgery are known to 

face a risk of neurodevelopmental impairment, 

particularly in the newborn 

period. But despite much research, 

there is no consensus on how to mitigate 

that risk. However, there is undeniable 

evidence, according to Charles 

D. Fraser, MD, of Texas Children’s 

Hospital, that the intraoperative period 

has measurable impact, and that 

this is the timeframe over which the 

surgeon has most control. 

“Given these observations, it is difficult 

to accept that the congenital 

heart surgeon should not perform at 

least some form of intraoperative 

neuromonitoring,” Dr. Fraser said. 

“Unlike in the past, today there are 

ways to provide meaningful information 

about cerebral blood flow and 

Ross M. Ungerleider, MD, discussed a 

modification of the Ross Procedure. 

brain oxygen content during an operation.” 

He discussed several methods 

by which such information could be 

used to potentially improve outcomes, 

concluding that, while unproven, 

it is of critical importance, 

and that the emphasis should shift 

from whether to monitor or not, to 

how to best use the information 

monitoring provides. 

Ross M. Ungerleider, MD, of Wake 

Forest Baptist Health, discussed a “reinforced” 

modification of the Ross 

Procedure that includes valve-sparing 

root reconstruction, which can expand 

the patients who will benefit. 

MARTIN ALLRED 

The AATS Daily News 

The Official Newspaper of the AATS 

93 rd Annual Meeting 

AATS Staff 

Executive Director: 

Cindy L. VerColen 

Managing Editor: 

Lorraine M. O’Grady 

Publication Staff 

Director, IMNG Society Partners 

Mark Branca 

Advertising Sales: 

Betty Ann Gilchrist, 203-938-3156 

Manager, Onsite News Products: 

Mark Lesney 

Publication Editors: 

Therese Borden, Lora McGlade 

Designer: 

Elizabeth Lobdell 

Photographers: 

Martin Allred, Nick Piegari 

Production Specialist: 

Maria Aquino 

Cover photo courtesy Meet Minneapolis 

©Copyright 2013, American 

Association for Thoracic Surgery, 500 

Cummings Center, Suite 4550, Beverly, 

MA 01915 

Produced and distributed for AATS by 

IMNG Society Partners, Frontline Medical 

Communications. All rights reserved. No 

part of this publication may be reproduced 

or transmitted in any form, by any 

means, without prior written permission 

of the AATS. The opinions expressed in 

this publication are those of the presenters 

and authors, and do not necessarily 

reflect the views of the Association.


Cardiac Skills Course Reviewed New Technology 

State-of-the-art presentations on what’s new in 

the highly active area of aortic valve therapies, 

including transcatheter aortic valve replacement, 

opened Saturday’s Adult Cardiac Skills 

and Decision Making Course. 

As an alternative to TAVR, Mattia Glauber, 

MD, of the Heart Hospital Monasterio Foundation, 

discussed the results he and his colleagues 

obtained with minimally invasive aortic valve replacement 

(MIAVR) using a right anterior 

minithoracotomy (RT). “The procedure showed 

excellent surgical results in terms of mortality, 

morbidities, and patient satisfaction in our 

hands,” said Dr. Glauber. 

Vinod H. Thourani, MD, compared the transapical approach to 

aortic valve replacement with the transfemoral approach. 

Despite these excellent results, patients undergoing 

MIAVR via RT had longer cardiopulmonary bypass 

and aortic crossclamp times than those who 

received a full sternotomy. “This is a limitation to 

our approach, suggesting that exposure and implantation 

of the prosthetic valves are more challenging 

when performed minimally invasively,” he said. 

But Dr. Glauber believes the use of the sutureless 

valves, “which have shown excellent early clinical 

results, especially in terms of paravalvular 

leakages,” will probably reduce the operative 

times, further improving MIAVR using an RT approach. 

“In our experience with sutureless valves, 

we had a 50% reduction of operative times. We believe 

that MIAVR via RT with a sutureless prosthesis 

might be considered an ‘alternative’ to TAVI 

procedure for high-risk patients. However, a randomized 

trial is required to confirm this hypothesis,” 

Dr. Glauber concluded. 

In his presentation on the benefits of a transapical 

approach to aortic valve replacement, Vinod H. 

Thourani, MD, of Emory University, said that 

“compared to a transfemoral approach, transapical 

AVR is direct and antegrade, with the potential for 

minimal embolic neurologic events, no limitation 

to sheath diameter. ... It is also less time 

consuming, minimizes radiation, and 

minimizes contrast to elderly patients.” 

The session also focused on new 

technologies in the treatment of the 

aortic arch, the mitral valve, and atrial 

fibrillation, as well as on the latest generation 

of ventricular assist devices. 

Because ischemic mitral regurgitation 

occurs in up to 40% of patients after 

myocardial infarction and is 

associated with poor outcomes, the 

classical surgical treatment consists of 

concomitant revascularization and restrictive 

mitral annuloplasty, said 

Robert A. Dion, MD, of the Ziekenhuis 

Oost-Limburg. 

However, a high rate of mitral regurgitation 

recurrence is still seen at short 

and midterm follow-up and there is no 

evidence of prolonged survival. These 

results may reflect the variety of strategies 

and techniques used, according to Dr. Dion, 

which vary widely between institutions, and sometimes 

within a given team. 

Variables include the annuloplasty devices used 

(bands, rings complete vs. incomplete, rigid vs. pliable), 

the sizing of the device (intertrigonal distance 

vs. anterior leaflet surface vs. anterior leaflet height 

with or without the rough zone included), and the 

degree of undersizing. 

“A consensus seems to be developing of using a 

complete rigid or semirigid ring, with the degree 

of undersizing adapted to the type of ring used,” 

said Dr. Dion. 

“Recent studies, including our own, have 

demonstrated that, in patients with a not-too-dilated 

LV before the operation, a well performed 

RMA using a complete and rigid or semi-rigid ring, 

Mattia Glauber, MD, presented his work with 

minimally invasive aortic valve replacement. 

with sufficient undersizing and yielding a coaptation 

length of greater than or equal to 8 mm, consistently 

leads to better clinical outcome, reverse 

remodeling, functional improvement at exercise, 

stability of the repair result, and most probably, 

based on the more recent studies, to prolonged 

survival,” Dr. Dion concluded. 

Also at the session, Mark S. Slaughter, MD, of 

the University of Louisville, presented an 

anatomical slideshow demonstrating the implantation 

of the latest generation of ventricular assist 

devices. Dr. Slaughter showed the Heartmate II as 

done through a standard sternotomy and the 

Heartware HVAD implanted using a minimally 

invasive approach. 

The course was moderated by Rakesh M. Suri, 

MD, of the Mayo Clinic and Eric E. Roselli, MD, of 

the Cleveland Clinic. 

MARTIN ALLRED 

Plan to Attend the AATS 

Annual Business Meeting 

Business Session 

Monday, May, 6 

7:30 a.m. – 7:45 a.m. 

Executive Session 

Tuesday, May 7 

5:15 p.m. – 5:45 p.m. 

AATS Members Only 

MARTIN ALLRED 

Social Media: The Whats, Whys and Hows 

Lee Aase, Director of the 

Mayo Clinic Center for 

Social Media, spoke on 

Saturday and Sunday on 

using social networking 

to improve the AATS 

meeting experience and 

how social media, 

including Facebook and 

Twitter can be used to 

improve medical 

communication.

What does “less invasive” 

mean to you? 

Positioning all 

the pieces for 

a perfect fit 

To us at Sorin Group less invasive 

represents a continuing paradigm in 

patient treatment to improve quality 

and achieve better outcomes. 

However, a less invasive approach 

comes with increased demands where 

 

to achieve maximum results. 

Sorin Group innovations enable you to 

optimize your less invasive cardiac 

procedures clinically and economically 

 

Please visit us at booth #1019. 

Sorin Group USA, Inc. 

14401 W. 65th Way, Arvada, CO 80004 

United States of America 

Tel. 800.289.5759 Fax 877.657.3605 

© 2013 Sorin Group www.sorin.com

Monday - Thoracic Surgery News

Create successful ePaper yourself

Delete template?

Save as template?